SEC Filing Summary: Amedica Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Amedica Corporation on November 10, 2016. The report serves to disclose the company's financial results for the third quarter of 2016. The filing incorporates a press release dated November 10, 2016, as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1), which is referenced but not included in the source text.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the main text. It directs readers to the attached press release for the third quarter 2016 results.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary, risks, contingencies, or unusual items. It notes that the information under Item 2.02 and the attached exhibit is deemed "filed" rather than "furnished" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the specific revenue and net income figures for Q3 2016 in the attached Exhibit 99.1 press release.
- Confirm the company's cash position and liquidity status as detailed in the full financial results.
- Review the press release for any forward-looking statements or updated guidance not present in this summary.
- Note the discrepancy between the request metadata (Sintx Technologies) and the filing registrant (Amedica Corporation).